Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharmaceutical Industries fixes record date for final dividend
Record date is 07 July 2026
Manipal Health leases Bengaluru hospital asset on nearly 30-year pact
Manipal Health Enterprises has secured a large hospital building in Bengaluru on a long-term lease. The deal spans almost 30 years, with a total rental commitment of around Rs 500 crore. This expansion follows recent acquisitions and property deals. The company is growing its network to meet rising healthcare demand.
Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a month
Despite weakness in the broader market, seven BSE 500 stocks including Honasa Consumer, Aegis Logistics and Gland Pharma scaled fresh 52-week highs, gaining up to 35% over the past month amid strong investor buying.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.

Bank of Baroda, Cipla, RIL, HDFC AMC Dividend Record Date: Last Day To Buy Shares To Qualify
Dividend Record Date: Last Day To Buy Shares To Qualify
Rubicon Research jumps 15% to hit 52-week high on Q4 results, dividend news
Along with its quarterly results, the board recommended a dividend of ₹1.50 per equity share of face value ₹1 each, fully paid up, for the financial year ended March 31, 2026

Dividend, Bonus Issues This Week: RIL, Trent, Cipla, Ashok Leyland And More
Trent Ltd has fixed June 4 as the record date for a 1:2 bonus issue.

Dividend, stock split, buybacks this week: Wipro, RIL, Cipla, Trent, Ashok Leyland, JSW Energy, among others in focus - Upstox
Dividend, stock split, buybacks this week: Wipro, RIL, Cipla, Trent, Ashok Leyland, JSW Energy, among others in focusUpstox

Glenmark Pharma Q4 net profit zooms to ₹301 crore; recommends 250% dividend
Glenmark's Q4FY26 profit surged to ₹301.4 crore, marking a rise of over 6,400% from ₹4.6 crore a year earlier. Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,274.25, down by ₹108.40, or 4.55%, on the BSE today, May 30.